BENEFIT Extension Study

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

NCT00928967 ·Status: COMPLETED

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

NCT00459667 ·Status: COMPLETED ·Phase: PHASE3

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

NCT00235989 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)

NCT00313976 ·Status: WITHDRAWN ·Phase: PHASE3

Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

NCT00493116 ·Status: COMPLETED ·Phase: PHASE4

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

NCT03347370 ·Status: COMPLETED

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)

NCT01706055 ·Status: COMPLETED

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

NCT00370071 ·Status: COMPLETED ·Phase: PHASE3

Depression and Fatigue in MS Patients Treated With Betaferon.

NCT01354665 ·Status: COMPLETED

BEYOND Pilot Study

NCT00893217 ·Status: COMPLETED ·Phase: PHASE2

Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

NCT00492466 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Safety and Efficacy Study of Peginterferon Beta-1a

NCT01332019 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

NCT01142518 ·Status: COMPLETED

Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis

NCT00468182 ·Status: COMPLETED

Physical Disability in Patients Treated With Betaferon

NCT00873340 ·Status: COMPLETED

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

NCT00461396 ·Status: COMPLETED

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

NCT01491100 ·Status: COMPLETED

National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis

NCT02937285 ·Status: COMPLETED ·Phase: PHASE3

BAY86-5046 (Betaseron), Non Interventional Studies

NCT02121444 ·Status: COMPLETED

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

NCT00317941 ·Status: COMPLETED ·Phase: PHASE4

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

NCT01031459 ·Status: COMPLETED

Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

NCT00492765 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

NCT00906399 ·Status: COMPLETED ·Phase: PHASE3

BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

NCT00382629 ·Status: COMPLETED ·Phase: PHASE2

Rehabilitation Study in MS Patients

NCT00780455 ·Status: TERMINATED ·Phase: PHASE4